Gideon Blumenthal has been appointed acting deputy office director of the Office of Hematology and Oncology Products at FDA. Blumenthal is a medical oncologist and serves as the associate director of precision therapeutics in OHOP. The appointment was announced by Richard Pazdur, director of the Oncology Center of Excellence and OHOP acting director. Blumenthal previously...
The Biden administration has left NIH in a weakened state, intensifying politicization of science on Capitol Hill and eroding the bipartisan support the government’s premier biomedical research agency has traditionally enjoyed.
